Global Rheumatoid Arthritis Drugs Market Expected To Hit US$ 70 Billion By 2030

Palm Beach, FL – December 30, 2022 – News Commentary – According to the Centers for Disease Control and Prevention, arthritis affects approximately one in every four Americans, or 58.5 million people. The global rheumatoid arthritis drugs market is expected to benefit significantly from increased launches of innovative biologics and expanding generic medication penetration. […]

Silo Pharma Announces Positive Study Results of SPU

21 for Arthritis – SPU-21 effective in controlling arthritis progression   SPU-21 Demonstrates Positive Data in Arthritis Suppression using Silo’s Novel Joint Homing Peptide    Englewood Cliffs, –  December 30, 2022 – Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, today announced positive […]